PDP - ETF AI Analysis
Top Page
Invesco DWA Momentum ETF (PDP)
PDP, the Invesco DWA Momentum ETF, has a solid overall rating driven mainly by strong momentum and financial performance from key holdings like Apple and Micron, which benefit from leadership in technology and growth areas such as services, AI, and advanced memory. However, weaker names like SanDisk and Guardant Health, which face financial and valuation challenges, weigh somewhat on the fund’s quality. The main risk is that many top holdings are high-growth, momentum-driven tech and healthcare companies, so the ETF can be more volatile and sensitive to shifts in market sentiment toward these sectors.
PDP vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.44B
- Region
- North America
- Expense Ratio
- 0.62%
- Beta
- 1.15
- Issuer
- Invesco
- Inception Date
- Mar 01, 2007
- Dividend Yield
- 0.25%
- Asset Class
- Equity
- Index Tracked
- Dorsey Wright Tech Leaders TR
PDP Summary
PDP is the Invesco DWA Momentum ETF, which follows the Dorsey Wright Technical Leaders Index. It focuses on U.S. companies whose stock prices have been rising strongly, aiming to invest in current market leaders across many sectors like technology, health care, and industrials. Well-known holdings include Apple and Micron. Someone might invest in PDP to seek growth and to spread their money across many strong-performing companies instead of picking individual stocks. A key risk is that momentum stocks can fall quickly if trends reverse, and the ETF can go up and down sharply with the overall stock market.
How much will it cost me?
The ETF has an expense ratio of 0.62%, which means you’ll pay about $6.20 per year for every $1,000 you invest. This cost is higher than the average ETF because it follows an actively managed momentum strategy rather than a simple passive index.
What would affect this ETF?
PDP could benefit if U.S. stocks, especially technology, health care, and industrial companies like Apple and Micron, continue to rise and if economic growth and innovation stay strong, since its momentum strategy focuses on recent winners. On the downside, a market downturn, higher interest rates, or a shift away from growth and tech stocks could hurt performance, and momentum strategies can struggle when trends reverse quickly or become choppy.
PDP Top 10 Holdings
PDP is leaning hard into U.S. momentum names, with a clear tilt toward tech and health care. Lumentum, Natera, and Guardant Health have been the real spark plugs lately, riding strong momentum tied to AI and precision medicine themes. Targa Resources adds an energetic boost from the midstream energy space, while Apple provides a steadier, blue-chip backbone that’s still rising but no longer sprinting. On the softer side, Amphenol and Trane look more mixed, occasionally losing steam and tempering returns, but the overall story is a fund chasing fast-moving U.S. growth leaders.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 AAPL | Apple | 3.26% | $45.62M | $5.03T | 26.98% | 79Outperform |
 APH | Amphenol | 2.99% | $41.90M | $195.55B | 14.01% | 78Outperform |
 TRGP | Targa Resources | 3.03% | $42.41M | $67.54B | 107.89% | 74Outperform |
 LITE | Lumentum Holdings | 2.44% | $34.12M | $76.15B | 320.08% | 61Neutral |
 SNDK | SanDisk Corp | 1.96% | $27.41M | $166.34B | 487.73% | 55Neutral |
 MU | Micron | 2.10% | $29.39M | $1.00T | 294.96% | 79Outperform |
 GWW | WW Grainger | 2.30% | $32.24M | $64.02B | 42.14% | 73Outperform |
 GH | Guardant Health | 1.87% | $26.19M | $23.99B | 93.49% | 61Neutral |
 TT | Trane Technologies | 1.64% | $22.94M | $89.75B | -8.15% | 70Outperform |
 NTRA | Natera | 1.68% | $23.56M | $59.72B | 114.42% | 73Outperform |
PDP Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PDP, the sentiment is Negative. The current price of 132.99 is below the 20-day moving average (MA) of 136.99, below the 50-day MA of 136.24, and below the 200-day MA of 134.58, indicating a bearish trend. The MACD of -0.59 indicates Positive momentum. The RSI at 40.67 is Neutral, neither overbought nor oversold. The STOCH value of 70.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PDP.
PDP Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| PDP | $132.99 | $147.00(10.53% Upside) | $1.44B | 0.62% | 71Outperform |
 BBUS | $136.12 | $168.40(23.71% Upside) | $9.75B | 0.02% | 73Outperform |
 QLTY | $43.56 | $52.77(21.15% Upside) | $5.49B | 0.50% | 75Outperform |
 DSI | $142.93 | $178.62(24.97% Upside) | $5.47B | 0.25% | 74Outperform |
 VTHR | $332.77 | $419.68(26.12% Upside) | $4.90B | 0.06% | 73Outperform |
 AKRE | $59.09 | $71.20(20.49% Upside) | $4.89B | 0.98% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| PDP | Invesco DWA Momentum ETF | 132.99 | 11.65 | 9.60% | |
| BBUS | JP Morgan Betabuilders U.S. Equity ETF | 136.12 | 13.64 | 11.14% | |
| QLTY | GMO U.S. Quality ETF | 43.56 | 6.51 | 17.56% | |
| DSI | iShares MSCI KLD 400 Social ETF | 142.93 | 14.04 | 10.90% | |
| VTHR | Vanguard Russell 3000 ETF | 332.77 | 35.06 | 11.78% | |
| AKRE | Akre Focus ETF | 59.09 | -5.54 | -8.57% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.